These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 30852710)
1. Phenibut (β-Phenyl-γ-Aminobutyric Acid): an Easily Obtainable "Dietary Supplement" With Propensities for Physical Dependence and Addiction. Jouney EA Curr Psychiatry Rep; 2019 Mar; 21(4):23. PubMed ID: 30852710 [TBL] [Abstract][Full Text] [Related]
2. Phenibut: A drug with one too many "buts". Gurley BJ; Koturbash I Basic Clin Pharmacol Toxicol; 2024 Oct; 135(4):409-416. PubMed ID: 39197876 [TBL] [Abstract][Full Text] [Related]
3. Management of Phenibut Use Disorder and Withdrawal in a Geriatric Patient. Wainblat E; Weleff J; Anand A Am J Geriatr Psychiatry; 2023 Jan; 31(1):67-74. PubMed ID: 36266201 [TBL] [Abstract][Full Text] [Related]
5. Toxidrome of an Easily Obtainable Nootropic: A Case Report of Phenibut Intoxication and Withdrawal Delirium. Martin R; Buffenstein I; Cho D; Kiyokawa M J Clin Psychopharmacol; 2023 Nov-Dec 01; 43(6):507-510. PubMed ID: 37930202 [TBL] [Abstract][Full Text] [Related]
6. Safety and Tolerability of the Anxiolytic and Nootropic Drug Phenibut: A Systematic Review of Clinical Trials and Case Reports. Kupats E; Vrublevska J; Zvejniece B; Vavers E; Stelfa G; Zvejniece L; Dambrova M Pharmacopsychiatry; 2020 Sep; 53(5):201-208. PubMed ID: 32340063 [TBL] [Abstract][Full Text] [Related]
8. A Case of Phenibut Withdrawal Management and Detoxification Using Baclofen in the Outpatient Setting. DiFiore E; Pittman J Case Rep Psychiatry; 2024; 2024():8824770. PubMed ID: 38993282 [TBL] [Abstract][Full Text] [Related]
9. Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Owen DR; Wood DM; Archer JR; Dargan PI Drug Alcohol Rev; 2016 Sep; 35(5):591-6. PubMed ID: 26693960 [TBL] [Abstract][Full Text] [Related]
10. A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal. Feldman R; Autry B; Dukes J; Lofy T; Marchetti G; Patt A; Batterman N; Theobald J Clin Toxicol (Phila); 2023 Nov; 61(11):941-951. PubMed ID: 38112312 [TBL] [Abstract][Full Text] [Related]
11. Case Report of Physiologic Phenibut Dependence Treated With a Phenobarbital Taper in a Patient Being Treated With Buprenorphine. Brunner E; Levy R J Addict Med; 2017; 11(3):239-240. PubMed ID: 28441273 [TBL] [Abstract][Full Text] [Related]
12. Phenibut: A Novel Nootropic With Abuse Potential. Mash JE; Leo RJ Prim Care Companion CNS Disord; 2020 Aug; 22(4):. PubMed ID: 32791574 [No Abstract] [Full Text] [Related]
13. Phenibut: Review and Pharmacologic Approaches to Treating Withdrawal. Penzak SR; Bulloch M J Clin Pharmacol; 2024 Jun; 64(6):652-671. PubMed ID: 38339875 [TBL] [Abstract][Full Text] [Related]
14. [Phenibut yielded withdrawal symptoms and psychosis. Drugs for cosmonauts--now marketed as dietary supplements online]. Högberg L; Szabó I; Ruusa J Lakartidningen; 2013 Apr 17-23; 110(16):825-7. PubMed ID: 23717928 [No Abstract] [Full Text] [Related]
19. Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. Lapin I CNS Drug Rev; 2001; 7(4):471-81. PubMed ID: 11830761 [TBL] [Abstract][Full Text] [Related]
20. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. Doyno CR; White CM J Clin Pharmacol; 2021 Aug; 61 Suppl 2():S114-S128. PubMed ID: 34396551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]